top of page
News
Charting a Course to Protect Consumers at Pharmacy Counters
There is an Inspector Clouseau quality to how Washington policymakers address the challenge of high prescription drug prices. For years,...
Aug 11, 2022
Fixing the PBM Problem Is the Silver Bullet for Lowering Drug Costs in America
Common Sense PBM Reforms Are Needed Now to Make Medicines More Affordable FOR IMMEDIATE RELEASE August 10, 2022 Washington, DC – Mark...
Aug 11, 2022
How the failure to cap insulin prices impacts Latinos
Failure to include a monthly $35 insulin cap in the climate and health care bill that passed the Senate last weekend could especially...
Aug 9, 2022
Opinion: Congress should seize opportunity to cut medication costs for consumers
Prices are on the rise on just about every category of goods and services: food, housing, and healthcare. Consumers could use a break....
Jul 25, 2022
Opinion: These 'Rebates' Don't Result in Savings
Two former Trump administration officials have taken to the Wall Street Journal to defend the practices of pharmacy benefit managers,...
Jul 22, 2022
Opinion: Drug Prices Are Falling, If You Know Where to Look
Prescription-drug prices are actually falling if you strip out the massive and growing rebates that pharmaceutical companies must pay...
Jul 21, 2022
Statement on Near-Term Congressional Efforts to Improve Prescription Drug Affordability
Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...
Jul 15, 2022
Opinion: San Diegans with Mental Health Issues Forego Treatment Due to High Cost
Rising health care costs continue to put treatment out of reach for vulnerable communities in San Diego and across California, including...
Jul 3, 2022
PBMs are inflating the cost of generic drugs. They must be reined in
hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...
Jun 30, 2022
Talking Solutions: The Story Behind Prescription Drug Prices In Nevada
According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...
Jun 27, 2022
PBM reform bill that boosts FTC powers inches closer to passage in Senate
Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...
Jun 22, 2022
Let My Doctors Decide: A VICTORY FOR PATIENTS
The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...
Jun 16, 2022
The National Consumers League applauds the FTC’s decision to investigate PBMs
NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power...
Jun 15, 2022
The Truth about Pharmacy Benefit Managers
Nobody wants fraud — particularly not in medical care. Accordingly, in 1972, Congress passed the Federal Anti-kickback Statute that...
Jun 9, 2022
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The...
Jun 8, 2022
Pharmacy Benefit Managers (PBMs) Harm Pharmacies and Patients Alike
Pharmacists play an essential role in the healthcare delivery system. Each day, their top priority is helping patients access medications...
May 25, 2022
PBM Accountability Project Applauds FTC for Examining the Cost-Increasing Impact of PBMs
The Executive Director of the PBM Accountability Project, Doug H. Dority, submitted public comment to the Federal Trade Commission (FTC)...
May 24, 2022
ICYMI | Grassley Press Release on Senate Commerce Committee Hearing
ICYMI | Grassley’s Leadership Recognized Multiple Times During Commerce Committee Hearing On Prescription Drug Pricing Reform WASHINGTON...
May 9, 2022
Highlights from Senate hearing on pharmacy benefit managers' role in drug prices
A U.S. Senate panel grilled secretive pharmacy benefit managers in a hearing Thursday on how to bring fairness and transparency to U.S....
May 6, 2022
Understanding where your money goes beyond the pharmacy counter
Where are the mystery costs your pharmacy absorbs and how does it affect your drugs and price? Key stakeholders share their expertise...
May 4, 2022
2021 Janssen Transparency Report
Our responsibility as a leader in the healthcare system is to bring forward actionable ideas, data and insights to help create a...
May 3, 2022
How to protect consumers from PBM greed
The rising cost of health care is a sore point for all consumers and nowhere is it more glaring than at the pharmacy counter. However,...
Apr 20, 2022
Howard Dean: It’s time to crack down on the middlemen that inflate the costs of drugs like insulin
U.S. Sen. Raphael Warnock just introduced a bill that would cap Americans’ out-of-pocket spending on insulin at $35 a month. The...
Apr 18, 2022
Rein In Profiteering by Drug-Industry Middlemen
The Federal Trade Commission recently requested public comments on the effect of drug-industry middlemen on drug affordability and...
Apr 11, 2022
bottom of page